FDA Investigator Mra M Barbosar
Mra M Barbosar has conducted inspections on 43 sites in 16 countries as of 13 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
43
Last Inspection Date:
13 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Spain,
Italy,
Hungary,
Germany,
France,
Belgium,
Poland,
United Kingdom of Great Britain and Northern Ireland,
Switzerland,
Ireland,
Denmark,
Netherlands,
Bulgaria,
Greece,
Czechia,
Sweden
FDA Investigators that have inspected at least one site in common with Mra M Barbosar:
Alan L Truong,
Alicia M Mozzachio,
Anastasia M Shields,
Angela E Glenn,
Ann Marie Montemurro,
Anna Lazar,
Anna M Brannen,
Anthony C Warchut,
Ashar P Parikh,
Azza Talaat,
Bo Chi, PhD,
Brandy N Lepage,
Brian D Nicholson,
Bryan A Galvez,
Burnell M Henry,
Candace Y Gomez Broughton,
Carla J Lundi,
Caryn M Mcnab,
CDR Ileana Barreto Pettit,
Charanjeet Jassal,
Charles L Zhou,
Charles R Cote, RIC,
Christina A Miller,
Christopher S Keating,
Constance Y Fears,
Corey K Reno,
Cynthia Jim, CSO,
David M Beltran,
Demitria J Xiradakis,
Dongping Dai, PhD,
Douglas C Kovacs,
Dr. Robert C Horan, MD,
Dr. Willie Wilson, PhD,
Dr. Zhihao Qiu (Peter), PhD,
Edwin Melendez,
Elizabeth A Waltrip,
Emest F Bizjak,
Erika V Butler,
Felix Maldonado,
Francis A Guidry,
George R Smith,
Gunther Boekhoudt, PhD,
Gwyn G Dickinson,
Hamet M Toure, PharmD MPH,
Helen B Ricalde,
Ivis L Negron,
Jacek Cieslak, PhD,
James K Ireland,
James L Dunnie, Jr,
James P Stumpff,
Janet L Bowen,
Janet Pulver,
Javier E Santos,
Jawaid Hamid,
Jeffrey A Sommers,
Jennifer M Gogley,
Jessica L Pressley,
Joey V Quitania,
Jose Acruz Gonzalez,
Joseph R Lambert,
Kalavati Suvarna, PhD,
Karen C Daugherty,
Katherine Szestypalow,
Kathleen R Jones, PhD,
Katie L Penno,
Kenneth H Williams,
Kham Phommachanh,
Kimberley A Hoefen,
Lance Mde Souza, MBA,
Laura Fontan, MS,
Laurie B Frazier,
LCDR Chad N Thompson,
Liatte Kreuger, PharmD,
Linda F Murphy,
Lourdes Valentin Aponte,
Lucas B Leake,
Mada A Tautges,
Madushini Dharmasena, PhD,
Margaret M Annes,
Marlene G Swider,
Massoud Motamed,
Matthew B Casale,
Maya M Davis,
Melanie M Walker,
Melissa D Ray,
Michael A Charles,
Michael E Maselli,
Michael L Casner,
Michael P Sheehan,
Michael R Goga,
Michael Shanks, MS,
Michele L Forster, PhD,
Michele L Obert,
Mihaly S Ligmond,
Mindy M Chou,
Mohsen Rajabi Abhari, FDA,
Monika Borkowska,
Mra Davism,
Mra Mcculloughj,
Nadeem I Chaudhry,
Nancy G Schmidt,
Nancy L Rolli,
Nicole E Knowlton,
Niketa Patel,
Noreen Muñiz,
Omotunde O Osunsanmi,
Pratik S Upadhyay, DDC,
Rachael A Moliver,
Ralph A Erickson,
Randy L Self,
Rebecca E Dombrowski,
Regina T Brown,
Reyes Candau Chacon, PhD,
Richard Ledwidge (nmi), PhD,
Robert J Ham,
Rochelle K Kimmel,
Rozelle G Smith,
Russell J Glapion,
Russell K Riley,
Saied A Asbagh,
Scott T Ballard,
Seneca D Toms,
Sharon K Thoma, PharmD,
Sidney B Priesmeyer,
Simone E Pitts,
Sixto M Mercado Rios,
Sonia R Peterson,
Sripal R Mada, PhD,
Stephen D Brown,
Steven A Gonzales,
Steven D Kehoe,
Steven M Weinman,
Steven P Donald,
Susan F Laska, MS,
Susan M Jackson,
Susanna E Ford,
Tamara J Umscheid,
Theresa Kirkham (NMI),
Thomas J Arista,
Tiara Nbrown Crosen,
Timothy T Kapsala,
Vilmary Negron Rodriguez,
Vincent M Williams,
Viviana Matta,
Vlada Matusovsky,
Warren J Lopicka,
Wayne T Smith,
Wendy G Tan, PhD,
Xiaoping Guan,
Yasamin Ameri,
Yumi J Hiramine,
Zhong Li, PhD
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more